Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBTB18 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CECR6 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | PGBD5 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | PCDHA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | UNC79 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | KCNH8 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | EIF2S2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | CHD4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |